Abstract:Wogonin, a plant-derived flavone, has been shown recently to have antitumor effects. However, the mechanisms that wogonin inhibits tumor angiogenesis are not well known. In this study, we investigated the effects of wogonin on expression of hypoxia-inducible factor-1α (HIF-1α) and secretion of vascular endothelial growth factor (VEGF) in tumor cells. We found that wogonin decreased the expression of HIF-1α by affecting its stability and reduced the secretion of VEGF, which suppressed angiogenesis in cancer. Wogonin promoted the degradation of HIF-1α by increasing its prolyl hydroxylation, which depended on prolyl hydroxylase (PHD) and the von Hippel–Lindau tumor suppressor (VHL). Intriguingly, wogonin impeded the binding between heat-shock protein 90 (Hsp90) and HIF-1α. In addition, wogonin down-regulated the Hsp90 client proteins EGFR, Cdk4 and survivin, but did not affect the level of Hsp90. Wogonin also increased ubiquitination of HIF-1α and promoted its degradation in proteasome. We also found that wogonin could inhibit nuclear translocation of HIF-1α. Electrophoresis mobility shift assay (EMSA) showed that wogonin decreased the binding activity of exogenous consensus DNA oligonucleotide with HIF-1α in nuclear extracts from MCF-7 cells. Chromatin immunoprecipitation (ChIP) assay also revealed that HIF-1α directly binded to endogenous hypoxia-responsive element (HRE) and this binding was significantly decreased in MCF-7 cells treated with wogonin. Preliminary results indicated in vivo activity of wogonin against xenograft-induced angiogenesis in nude mice. Taken together, the results suggested that wogonin was a potent inhibitor of HIF-1α and provided a new insight into the mechanisms of wogonin against cancers.

Wogonin Inhibits Latent HIV-1 Reactivation by Downregulating Histone Crotonylation

Wogonin Attenuates Inflammation by Activating PPAR-γ in Alcoholic Liver Disease.

Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections

Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui

Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways

Wogonin Inhibits Tumor Angiogenesis Via Degradation of HIF-1α Protein.

Anti-hepatitis B virus activity of wogonin in vitro and in vivo.

Wogonin Suppresses IL-10 Production in B Cells Via STAT3 and ERK Signaling Pathway.

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling

Scopoletin Reactivates Latent HIV-1 by Inducing NF-?B Expression without Global T Cell Activation

Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation

Retraction Note: Wogonin Reversed Resistant Human Myelogenous Leukemia Cells Via Inhibiting Nrf2 Signaling by Stat3/NF-κB Inactivation

Oxaliplatin Antagonizes HIV-1 Latency by Activating NF-κB Without Causing Global T Cell Activation.

Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway

Wogonin Reverses Multi-Drug Resistance of Human Myelogenous Leukemia K562/A02 Cells Via Downregulation of MRP1 Expression by Inhibiting Nrf2/ARE Signaling Pathway.

A Novel Selective Histone Deacetylase I Inhibitor CC-4a Activates Latent HIV-1 Through NF-κB Pathway.

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis.

Wogonin Suppresses Tumor Growth in Vivo and VEGF-induced Angiogenesis Through Inhibiting Tyrosine Phosphorylation of VEGFR2.

Anti-tumor Activity of Wogonin, an Extract from Scutellaria Baicalensis , Through Regulating Different Signaling Pathways

Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/beta-catenin/TCF1 axis in CD4(+) T cells